PF-00835231 is a 3CLpro (Mpro) inhibitor that may targets SARS-CoV-2 protease 3CLpro as a potential new treatment for COVID-19.
Properties:
Boiling point: 865.8±65.0 °C(Predicted)
density: 1.264±0.06 g/cm3(Predicted)
pka: 12.76±0.10(Predicted)
SARS-CoV Inhibitors Related Products:
Nafamostat; Nafamostat mesylate; PF-07321332; PLpro inhibitor; ML188; Molnupiravir N-1; Molnupiravir